The project “The role of tumor necrosis factor receptor 2 (TNFR2) in chronic lymphocytic leukemia: from biology to treatment”, carried out by Dr. Kai Ling Liang at the Nencki Institute of Experimental Biology of the Polish Academy of Sciences, has been selected for funding in a competition under the Top 200 im. Weigla programme. The project is financed from the state budget, provided by the National Centre for Research and Development (NCBR).

The research concerns the role of tumor necrosis factor receptor 2 (TNFR2) in chronic lymphocytic leukemia and aims to move from understanding the mechanisms of action of this receptor to developing new therapeutic approaches. The project will be carried out from 1 September 2026 to 29 February 2028.

The funding agreement was signed on 14 October 2026. The total project value and the funding amount are both PLN 400,000.00.